TGFBR2, transforming growth factor beta receptor 2, 7048
N. diseases: 502; N. variants: 76
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.080 | 3 | 30641447 | intron variant | G/C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.710 | 1.000 | 4 | 2013 | 2017 | ||||||||
|
0.882 | 0.080 | 3 | 30641447 | intron variant | G/C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.710 | 1.000 | 2 | 2013 | 2014 | ||||||||
|
1.000 | 0.040 | 3 | 30620836 | intron variant | C/G | snv | 0.72 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.080 | 3 | 30649419 | intron variant | A/G | snv | 0.25 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.080 | 3 | 30649419 | intron variant | A/G | snv | 0.25 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.080 | 3 | 30641447 | intron variant | G/C;T | snv |
|
0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 0.080 | 3 | 30642014 | intron variant | C/T | snv | 0.27 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 3 | 30639603 | intron variant | A/G | snv | 0.32 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 3 | 30643415 | intron variant | C/T | snv | 0.31 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 3 | 30656417 | intron variant | A/G | snv | 0.16 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.160 | 3 | 30691329 | intron variant | C/A | snv | 0.23 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
3 | 30668751 | intron variant | A/G | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2007 | 2007 | ||||||||||
|
3 | 30668751 | intron variant | A/G | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2007 | 2007 | ||||||||||
|
1.000 | 0.040 | 3 | 30677040 | intron variant | A/G | snv | 3.9E-02 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 3 | 30686798 | intron variant | G/C | snv | 0.14 |
|
Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 3 | 30686798 | intron variant | G/C | snv | 0.14 |
|
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.040 | 3 | 30627911 | intron variant | C/G | snv | 1.8E-02 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 3 | 30641799 | intron variant | A/G | snv | 0.66 |
|
0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
3 | 30657290 | intron variant | G/A | snv | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 30657290 | intron variant | G/A | snv | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 30657290 | intron variant | G/A | snv | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.827 | 0.240 | 3 | 30688470 | stop gained | C/G;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 6 | 2006 | 2016 | ||||||||
|
0.827 | 0.240 | 3 | 30688470 | stop gained | C/G;T | snv |
|
0.700 | 1.000 | 5 | 2004 | 2012 | |||||||||
|
0.882 | 0.120 | 3 | 30688476 | stop gained | C/A;T | snv | 4.0E-06 |
|
0.700 | 1.000 | 5 | 2004 | 2017 | ||||||||
|
1.000 | 0.120 | 3 | 30688482 | stop gained | G/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 2 | 2006 | 2006 |